HUNTER JOHN C III 4

What Happened John C. Hunter III, a director of Edgewell Personal Care Company (EPC), was granted 7,817 restricted stock equivalents on February 5, 2026. The award was reported as a derivative grant at $0.00 (no cash paid). This is an equity compensation award (code A), not a purchase or sale of outstanding shares.

Key Details

• Transaction date: 2026-02-05; Form 4 filed: 2026-02-09 (timely filing).
• Transaction type: Grant/award of restricted stock equivalents (derivative), 7,817 units, reported at $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: These restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders unless the reporting person elects to defer conversion until termination of Board service.
• Filing status: Timely (filed within the SEC’s Form 4 reporting window).

Context Restricted stock equivalents (RSEs) are a form of deferred equity compensation that convert into company shares per the plan terms; they are commonly used for director compensation and retention. Because no cash was exchanged and conversion may be deferred, this award is a compensation event rather than a direct market purchase or sale and should be interpreted accordingly.